Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-01

Clinical Trial Update: Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [NA]

View source ↗

Summary

This clinical trial update covers two-stage tuberculin skin testing (PPD) in individuals with HIV infection. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Tuberculosis | NA | Status: COMPLETED